SPL 0.00% 9.5¢ starpharma holdings limited

Starpharma's DEP® remdesivir versus Gilead's Veklury (Remdesivir), page-4

  1. 179 Posts.
    lightbulb Created with Sketch. 28
    Morningstar fair value rating for SPL is now: $2.29
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.